Vinorelbine plus trastuzumab combination as first-line therapy for HER 2-positive metastatic breast cancer patients: an international phase II trial

British Journal of Cancer ◽

10.1038/sj.bjc.6603351 ◽

2006 ◽

Vol 95 (7) ◽

pp. 788-793 ◽

Author(s):

A Chan ◽

◽

M Martin ◽

M Untch ◽

M G Gil ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Cancer Patients ◽

Phase Ii Trial ◽

Metastatic Breast ◽

Breast Cancer Patients ◽

First Line Therapy ◽

Line Therapy ◽

Download Full-text

Endocrine therapy or chemotherapy as first-line therapy in hormone receptor–positive HER2-negative metastatic breast cancer patients

European Journal of Cancer ◽

10.1016/j.ejca.2018.03.013 ◽

2018 ◽

Vol 95 ◽

pp. 93-101 ◽

Author(s):

E. Jacquet ◽

A. Lardy-Cléaud ◽

B. Pistilli ◽

S. Franck ◽

P. Cottu ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Cancer Patients ◽

Hormone Receptor ◽

Metastatic Breast ◽

Breast Cancer Patients ◽

First Line Therapy ◽

Hormone Receptor Positive ◽

Download Full-text

Retrospective review of Her2 positive metastatic breast cancer patients who received Pertuzumab and Herceptin as a first line therapy at KFSH&RC (single institute experience) from 2013 to 2016

10.1016/s0960-9776(19)30245-0 ◽

2019 ◽

Vol 44 ◽

pp. S64

Author(s):

K. Suleman ◽

A. Mushtaq ◽

E. Haque ◽

A. Badran ◽

D. Ajarim ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Cancer Patients ◽

Retrospective Review ◽

Metastatic Breast ◽

Breast Cancer Patients ◽

Her2 Positive ◽

First Line Therapy ◽

Download Full-text

Abstract OT-26-01: ABEMACARE: Abemaciclib in combination with endocrine therapy as first line therapy in metastatic breast cancer patients with symptomatic visceral metastases or high tumor burden

10.1158/1538-7445.sabcs20-ot-26-01 ◽

2021 ◽

Author(s):

Franziska Kotzur ◽

Helen Bidner ◽

Holger Bronger ◽

Silvia Egert ◽

Peter A Fasching ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Cancer Patients ◽

Metastatic Breast ◽

Tumor Burden ◽

Breast Cancer Patients ◽

First Line Therapy ◽

Line Therapy ◽

Visceral Metastases

Download Full-text

Abstract P1-12-07: A Retrospective Analysis ofnab-Paclitaxel as First-Line Therapy for Metastatic Breast Cancer Patients With Poor Prognostic Factors

10.1158/0008-5472.sabcs12-p1-12-07 ◽

2012 ◽

Author(s):

J O'Shaughnessy ◽

W Gradishar ◽

P Bhar ◽

J Iglesias

Keyword(s):

Breast Cancer ◽

Prognostic Factors ◽

Metastatic Breast Cancer ◽

Retrospective Analysis ◽

Cancer Patients ◽

Metastatic Breast ◽

Breast Cancer Patients ◽

First Line Therapy ◽

Download Full-text

Phase II Trial of a Novel Paclitaxel Schedule As Single-Agent, First-Line Therapy for HER-2/neu-Negative Metastatic Breast Cancer: A Community-Based Study

Journal of Oncology Practice ◽

10.1200/jop.2.6.268 ◽

2006 ◽

Vol 2 (6) ◽

pp. 268-273

Author(s):

D. Loesch ◽

N. Robert ◽

S. Jones ◽

M. Elkordy ◽

D. Ilegbodu ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Phase Ii Trial ◽

Single Agent ◽

Metastatic Breast ◽

Community Based ◽

First Line Therapy ◽

Line Therapy ◽

Download Full-text

Circulating tumor cells as prognostic and predictive markers in metastatic breast cancer patients receiving first-line therapy.

Journal of Clinical Oncology ◽

10.1200/jco.2010.28.15_suppl.1033 ◽

2010 ◽

Vol 28 (15_suppl) ◽

pp. 1033-1033 ◽

Author(s):

M. Giuliano ◽

A. Giordano ◽

L. Hsu ◽

B. C. Handy ◽

N. T. Ueno ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Cancer Patients ◽

Tumor Cells ◽

Metastatic Breast ◽

Breast Cancer Patients ◽

First Line Therapy ◽

Line Therapy ◽

Prognostic And Predictive Markers

Download Full-text

Trastuzumab as first-line therapy in HER2-positive metastatic breast cancer patients

Expert Review of Anticancer Therapy ◽

10.1586/era.12.107 ◽

2012 ◽

Vol 12 (11) ◽

pp. 1391-1405 ◽

Author(s):

Lucia Del Mastro ◽

Matteo Lambertini ◽

Claudia Bighin ◽

Alessia Levaggi ◽

Alessia D’Alonzo ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Cancer Patients ◽

Metastatic Breast ◽

Breast Cancer Patients ◽

Her2 Positive ◽

First Line Therapy ◽

Download Full-text

Docetaxel and pegylated liposomal doxorubicin combination as first-line therapy for metastatic breast cancer patients: results of the phase II GINECO trial CAPYTTOLE

Annals of Oncology ◽

10.1093/annonc/mdp231 ◽

2009 ◽

Vol 20 (12) ◽

pp. 1959-1963 ◽

Author(s):

C. de la Fouchardière ◽

R. Largillier ◽

Y. Goubely ◽

A.-C. Hardy-Bessard ◽

B. Slama ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Cancer Patients ◽

Liposomal Doxorubicin ◽

Metastatic Breast ◽

Pegylated Liposomal Doxorubicin ◽

Breast Cancer Patients ◽

First Line Therapy ◽

Download Full-text

Phase II Trial of Weekly Vinorelbine and Trastuzumab as First‐Line Therapy in Patients with HER2 + Metastatic Breast Cancer

The Oncologist ◽

10.1634/theoncologist.7-5-410 ◽

2002 ◽

Vol 7 (5) ◽

pp. 410-417 ◽

Author(s):

Mohammad Jahanzeb ◽

Joanne E. Mortimer ◽

Furhan Yunus ◽

David H. Irwin ◽

James Speyer ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Metastatic Breast ◽

First Line Therapy ◽

Download Full-text

Abstract P3-02-11: First Analysis of the Value of Circulating Epithelial Tumor Cells and Circulating Endothelial Cells (CTCs/CECs) in Patients with HER-2 Negative Recurrent or Metastatic Breast Cancer Treated with Bevacizumab in Combination with Paclitaxel and Gemcitabine as First Line Therapy (AVALUZ Trial)

10.1158/0008-5472.sabcs10-p3-02-11 ◽

2010 ◽

Author(s):

L Manso ◽

E Ciruelos ◽

M Codes de Villena ◽

J de la Haba ◽

A Galán ◽

...

Keyword(s):

Breast Cancer ◽

Endothelial Cells ◽

Metastatic Breast Cancer ◽

Metastatic Breast ◽

Circulating Endothelial Cells ◽

Epithelial Tumor ◽

First Line Therapy ◽

Line Therapy ◽

Download Full-text